ClinicalTrials.Veeva

Menu

Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Atrial Fibrillation

Study type

Observational

Funder types

Other

Identifiers

NCT00542659
2005-02-019

Details and patient eligibility

About

The role of plasma NT-proBNP, hsCRP, TIMP-1(Tissue inhibitors of MetalloProteinase-1),TGF-b, MMP-3(Matrix MetalloProteinase-3), and pro-MMP-1 in predicting the recurrence of AF after surgical Maze procedure.

The association of expression of CTGF, TGF-b, BNP, ANP, collagen-1, and collagen-3 in LA with the recurrence of AF after surgical Maze procedure.

Enrollment

86 estimated patients

Sex

All

Ages

30 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patients who have valvular heart disease with atrial fibrillation and are scheduled for operation

Exclusion criteria

  • Coronary heart disease
  • Congestive heart failure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems